US 7605126
Acylaminoheteroaryl hepatitis C virus protease inhibitors
granted A61PA61P31/14
Quick answer
US patent 7605126 (Acylaminoheteroaryl hepatitis C virus protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/14